OmniSeq
OmniSeq, an innovation of Roswell Park Comprehensive Cancer Center, is a molecular diagnostic laboratory based in Buffalo, N.Y. OmniSeq endeavors to find the right drug or the right trial for every patient by improving access to better cancer treatment options through genomic and immune profiling. OmniSeq offers three NGS-based assays: OmniSeq MSI NGS®, OmniSeq Advance®, and OmniSeq Comprehensive®.
Last updated on
About OmniSeq
Founded
2015Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$10MCategory
Industry
BiotechnologyLocation
City
BuffaloState
New YorkCountry
United StatesOmniSeq
Find your buyer within OmniSeq